Agnès Delfosse

Associate
Paris
About

Agnès Delfosse concentrates her practice on domestic and cross-border M&A transactions, including acquisitions, disposals (whether structured as share deals or asset deals), mergers, reorganizations, joint ventures, strategic alliances, and partnerships, as well as corporate law matters, financings, and venture capital investments.

She advises clients across a broad range of industries, with particular depth in regulated sectors such as life sciences and financial services. Her clients include leading industrial groups, pharmaceutical and medical device companies, biotechnology companies, investment funds, banks, and other financial institutions.

A member of both the Paris Bar and the State Bar of California, Agnès spent five years of her professional career practicing in the United States. Her experience spans both French and U.S. jurisdictions, enabling her to guide clients through complex multi-jurisdictional matters with confidence and precision.

Areas of FocusCorporatePrivate EquityMergers and AcquisitionsTechnologyLife Sciences
Professional QualificationsAvocate admitted to the Paris BarAttorney-at-law admitted with the State Bar of California

EXPERIENCE

  • Advising Halma, the global group of life-saving technology companies, on the cross-border acquisition of 100% of the shares and voting rights in French-based Lamidey Noury Medical, reinforcing its international footprint between France and England & Wales.
  • Advising Chemonics International, Inc., a global sustainable development firm, on its acquisition of D.M.I, a French international development company. 
  • Advising Stryker in connection with the acquisition of SERF SAS.
  • Advising Pierre Fabre on the sale of the Centre Immunologie Pierre Fabre, located in Saint-Julien-en-Genevois, together with the research and development activities carried out at the site, to Jubilant Group, an international Indian pharmaceutical group seeking to expand its CRO activities in Europe through the acquisition of a pharmaceutical site. 
  • Advising Renault group on the sale of its Irish business in Ireland.
  • Advising Société Générale on its acquisition of Shine, a French fintech and neobank.
  • Advising Sodexo on its sale of its worldwide home care division.
  • Advising a world-renowned health care provider and insurer on its co-investment in the approximately EUR4.7m offering of GenSight Biologics. 
 

Languages
  • French
  • English

AWARDS AND RECOGNITION

Team recognitions

  • Legal 500 EMEA 2025 - Private Equity: LBO - Tier 3
    “Availability, in-depth expertise, ability to support both SMEs and large international groups.”
  • Legal 500 EMEA 2025 - Mergers & acquisitions - Tier 4
    “Great organisational capabilities combined with a focused professional approach and excellent connections worldwide.”
  • Option Droit & Affaires – Mergers & acquisitions – 5 stars – 2025
  • Option Droit & Affaires – Private Equity – 5 stars - 2025
 
Education
  • University of UCLA, School of Law, LL.M. in business law, 2019
  • University of Paris II Panthéon-Assas, Master’s degree (M2) in Banking and Finance law (Master 2 de droit bancaire et financier), 2015
  • Université of Paris V Descartes, Master’s degree (M2) in Contracts and Secured Transactions (Master 2 de droit des obligations civiles et commerciales), 2014

Prior Experience

  • Before joining DLA Piper, Agnès was a U.S. associate in a top law firm for global M&A in the United States. She also has worked for a U.S. law firm’s Paris office in the Corporate and M&A department. She also has experience working as counsel for the legal department of a privately held finance company based in Los Angeles.

My latest insights

News

DLA Piper advises Virbac on acquisition of innovative feline drug from Norbrook

22 January 2026

CallvCardLinkedInPrint

Connect

Phone

+33 (0) 1 40 15 24 01
(Work, Paris)